Olema Oncology, Inc. (OLMA)

Olema Oncology, Inc. (OLMA) is a healthcare company (biotechnology) based in the United States. The share price is $7.21, down 2.11% on the day, which values the company at $631.2M. Price as of 17 Nov 2026, 17:30 UTC, from Yahoo Finance.

Key facts

Share price
$7.21−2.11% today
Market value
$631.2M
200-week average
$10.6532% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Olema Oncology, Inc. in more detail

OLMA trades at -2.5× next year's expected earnings. It sits 32% below its 200-week average of $10.65.

In its favour: More cash than debt. Worth checking: Weak Piotroski score; Share count keeps rising.

1 of the superinvestors tracked here hold OLMA, including Stanley Druckenmiller (0.3% of the portfolio).

Superinvestors holding OLMA

1 of the investors tracked here report a position in their latest 13F filing.

Olema Oncology, Inc. (OLMA): questions and answers

What is Olema Oncology, Inc.'s market cap?

Olema Oncology, Inc. is valued at $631.2M at a share price of $7.21.

Is OLMA above its 200-week moving average?

No. OLMA is 32.4% below its 200-week average of $10.65. Long-term investors watch that line because strong companies rarely trade below it for long.

Does OLMA pay a dividend?

Olema Oncology, Inc. does not currently pay a regular dividend.

Which famous investors own OLMA?

In their latest quarterly filings, Stanley Druckenmiller (0.3% of the portfolio) hold OLMA. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “Olema Oncology, Inc. (OLMA) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/OLMA

Underlying data: Yahoo Finance; company filings with the SEC.